For up to date information regarding COVID-19 in South Africa, please visit sacoronavirus.co.za
Research Themes
-
HIV Treatment Outcomes and Guidelines
-
Linkage, Retention and Adherence for HIV Treatment in South Africa
-
Costs, Cost-Effectiveness and Benefits of HIV Care and Treatment
-
Tuberculosis and HIV in South Africa
-
Cost and Budget Modelling
-
Sexual and Reproductive Health
-
Primary Health Care
-
Non-Communicable Diseases
-
Research Capacity Building
Research Programs
-
Evaluations to Inform Decisions using Economics and Epidemiology (EVIDENCE)
-
Indlela: Behavioural Insights for Better Health
-
COVID-19 Response
-
Economic Impact of HIV
-
CETA
-
Undetectable=Untransmittable” into HIV Counselling in South Africa (INTUIT-SA)
-
Retain6: Models of care for the first 6 months of HIV treatment
-
South African HIV Investment Case
-
Innovations Research on AIDS (INROADS)
-
AMBIT: Alternative Models of ART Delivery – Optimizing the Benefits
-
NHLS National HIV Cohort
-
Journal Articles
Induction-phase treatment costs for cryptococcal meningitis in high HIV-burden African countries: New opportunities with lower costs [version 3; peer review: 2 approved, 1 approved with reservations]
Abstract
Introduction: Access to and the cost of induction treatment for cryptococcal meningitis (CM) is rapidly changing. The newly announced price for flucytosine ($0.75 per 500 mg pill) and possibly lower prices for liposomal amphotericin B (AmB-L) create opportunities to reduce CM treatment costs compared to the current standard treatment in low- and middle-income countries. ... -
Journal Articles
Health Technology Assessment in Support of National Health Insurance in South Africa
Abstract South Africa has embarked on major health policy reform to deliver universal health coverage through the establishment of National Health Insurance (NHI). The aim is to improve access, remove financial barriers to care, and enhance care quality. Health technology assessment (HTA) is explicitly identified in the proposed NHI legislation and will have a prominent ...
-
Journal Articles
TB morbidity estimates overlook the contribution of post-TB disability: evidence from urban Malawi
ABSTRACT Introduction: Despite growing evidence of the long term impact of tuberculosis (TB) on quality of life, Global Burden of Disease (GBD) estimates of TB-related disability-adjusted life years (DALYs) do not include post TB morbidity, and evaluations of TB interventions typically assume treated patients return to pre-TB health. Using primary data, we estimate years of ...
- There are no vacancies, fellowships/interships at the moment.
- HE2RO is not currently offering any courses. Please keep checking back on the website for updates
Stay up to date
Receive newsletters and keep up to date with developments at HE2RO.
News
-
Indlela Request for Proposals: Behavioural Insights Tests (BITs)
...
-
HE2RO contributes to NDOH’s Covid-19 modelling
We are pleased to announce that we are now able to share the reports on the projections of the National Covid-19 Epi Model to which...
-
HE2RO has been awarded a new 5-year Co-operative Agreement from USAID
HE2RO has been awarded a new 5-year Co-operative Agreement from USAID. This new program, the HIV/AIDS Economics and Research Activity, called EVIDENCE will run...
